Skip to content

English

Facebook LinkedIn YouTube

Search for:

HOME
PRODUCTS
- LABS | HOSPITALS | DOCTORS
  INTERNATIONAL CATALOG
  BSX READER
  BACTERIOLOGY
  PARASITOLOGY
  MYCOLOGY
  VIROLOGY
  COVID-19
  BIOCHEMISTRY
  WOMEN’S HEALTH
  INSTRUMENTS
  MOLECULAR BIOLOGY
- PHARMACY | GPO | DISTRIBUTION | RETAIL
  SELF-TESTS
  SELF-MEASUREMENT
  MEDICAL AIDS
  ORAL CARE
  THERMOTHERAPY
COMPANY
R&D
CONTACT
NEWS

Search for:

COVID-19 Antigen detection tests

Home/Featured Solutions/COVID-19 Antigen detection tests

Previous Next

COVID-19 Antigen detection testsisaac2021-01-29T11:43:12+01:00

Project Description

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) in France and internationally. The RDTs, in their professional version, allow a better medical management of the patients thanks to the speed of their result and their simplicity of use. In their self-test version, they allow the general public self-monitoring of various pathologies thus ensuring better prevention and accelerating the demand for care.

BIOSYNEX COMPANY

Home
About us
Results
PHARMACY | RETAIL
LABORATORIES | HOSPITALS
News
Carriers
Contact

NEWS

THERADIAG Announces That BIOSYNEX Has Filed a Voluntary Takeover Bid for Its Shares
BIOSYNEX has acquired PARAKITO

© Copyright | All Rights Reserved | Biosynex®

Facebook LinkedIn YouTube

Toggle Sliding Bar Area

Laboratoire Biosynex

Recent

THERADIAG Announces That BIOSYNEX Has Filed a Voluntary Takeover Bid for Its Shares
September 23rd, 2022
BIOSYNEX has acquired PARAKITO
April 20th, 2022
Biosynex acquires Avalun to become European leader in rapid diagnostic testing
May 27th, 2021

test

test